Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Beacon Biosignals

Request full access

AI-driven EEG biomarkers for brain health

Boston, United StatesFounded 2019Biotech & Life Sciences

About Beacon Biosignals

Beacon Biosignals is a Boston-based neurotechnology company that applies machine learning to electroencephalography (EEG) and sleep data to produce quantitative biomarkers of brain function. The company was founded in 2019 by physician-scientists and engineers from Harvard and MIT, and it focuses on neurological, psychiatric and sleep disorders, areas where objective clinical measures have historically been scarce.

The company's core offering, the Beacon Platform, combines a large clinical EEG database with proprietary algorithms that detect features such as epileptiform activity, sleep architecture and other electrophysiological signatures. Data are collected in patients' homes using FDA-cleared wearable devices, including the Waveband headband, which records brain activity during sleep and wake, alongside home sleep-testing hardware that measures airflow, respiratory effort and blood oxygen saturation.

Beacon's main customers are biopharmaceutical and biotechnology companies developing therapies for the central nervous system. They use the platform for patient selection, pharmacokinetic and pharmacodynamic studies, dose finding and quantitative clinical trial endpoints in conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, narcolepsy, depression and sleep apnea. The company also works with academic medical centers and develops AI-assisted diagnostic tools intended for clinical use.

Beyond trial services, Beacon is building a foundation model of brain activity trained on millions of hours of EEG recordings, with the aim of identifying early disease signatures and predicting how individual patients respond to treatment.

Source: Dealroom company data

At a glance

Status
Operational
Employees
131
Open positions
5
Dealroom signal
93.5/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotechnology, Drug Development, Neurology, Core AI, Precision Medicine, Techbio, Hard Tech
Technology
Artificial Intelligence, Deep Tech
Business model
SaaS
Client focus
B2B
Investment activity
1 company, latest Jul 2023
Capital deployed
—
Preferred round
ACQUISITION

Open roles

20 open roles
RoleTeamLocationPosted
Marketing CoordinatorMarketingMarketingBoston, MA / Remote2d ago
Director, Alliance ManagementNew York, NY2d ago
Quality EngineerEngineeringEngineeringBoston, MA / Remote2d ago
Senior Mobile App Engineer (React Native)EngineeringEngineeringBoston, MA / Remote4d ago
Business Development AssociateSalesSalesBoston, MA / Remote6d ago
Logistics & Distribution ManagerOperationsOperationsBoston, MA / Remote6d ago
Senior Algorithm EngineerEngineeringEngineeringBoston, MA / Remote1w ago
Clinical Study Operations AssociateClinicalClinicalRemote1w ago
Senior IT SpecialistEngineeringEngineeringBoston, MA / Remote1w ago
Fulfillment Automation Solutions EngineerCustomerCustomerBoston, MA / Remote1w ago
Logistics & Demand Planning DirectorOperationsOperationsBoston, MA / Remote3w ago
Hardware Test EngineerEngineeringEngineeringBoston, MA3w ago
From the company's careers page. The newest 12 of 20. Careers page ↗More startups hiring →

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Apr 2026 $11M $430M Palo Santo Venture Fund · Samsung Next · Kicker Ventures · JSL Health Capital ↗
SERIES BOther financing Nov 2025 $86M $344M General Catalyst · GV · Casdin Capital · Indicator Ventures ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Beacon Biosignals website traffic

Latest recorded traffic for Beacon Biosignals is 19K monthly website visits, up 58.3% over the last three months. Beacon Biosignals's team grew 21.3% over the past year.

Latest monthly visits19K 3-month web change+58.3% 1-year team growth+21.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Beacon Biosignals in the Boston ecosystem

Live from Dealroom

The Beacon Biosignals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A15 investors entered at this stage

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Beacon Biosignals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.